Monitoring the transition to new antiretroviral treatment regimens through an enhanced data system in Kenya.

ABSTRACT:

Background

While the scale-up of HIV services has improved national health management information systems (HMIS), there remain challenges in using routine data to guide the introduction of optimized antiretroviral (ARV) drugs.

Methods

Building on the recent enhancements to the HMIS in Kenya and coinciding with the introduction of a new ARV regimen, tenofovir+lamivudine+dolutegravir (TLD), we developed and implemented an enhanced data system (EDS) to improve availability of safety and efficacy data among people living with HIV (PLHIV) in Kenya. Using data from one health facility, we showcase how the EDS can be used to monitor ARV transition and identify missed opportunities to transition eligible patients to optimized regimes.

Results

The EDS was designed to create a

SUBMITTER: Lahuerta M 

PROVIDER: S-EPMC7179904 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature